<div id="readability-page-1"><p>Norges Bank purchased a new stake in shares of  Cabot Corporation (NYSE:CBT - Free Report) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 689,470 shares of the specialty chemicals company's stock, valued at approximately $51,710,000. Norges Bank owned about 1.30% of Cabot as of its most recent SEC filing.</p><ul><li>10 Best Natural Gas Stocks to Buy Now</li></ul><p>Several other hedge funds have also recently made changes to their positions in the stock. Keeley Teton Advisors LLC boosted its holdings in  Cabot by 1.0% in the first quarter. Keeley Teton Advisors LLC now owns 16,756 shares of the specialty chemicals company's stock worth $1,393,000 after purchasing an additional 174 shares during the last quarter.  Franklin Resources Inc. lifted its holdings in shares of  Cabot by 1.7% during the 2nd quarter. Franklin Resources Inc. now owns 10,551 shares of the specialty chemicals company's stock valued at $791,000 after buying an additional 181 shares during the period.  Parkside Financial Bank &amp; Trust boosted its stake in shares of  Cabot by 95.5% in the 2nd quarter. Parkside Financial Bank &amp; Trust now owns 387 shares of the specialty chemicals company's stock worth $29,000 after buying an additional 189 shares during the last quarter.  Ferguson Wellman Capital Management Inc. boosted its stake in shares of  Cabot by 4.2% in the 2nd quarter. Ferguson Wellman Capital Management Inc. now owns 5,000 shares of the specialty chemicals company's stock worth $375,000 after buying an additional 200 shares during the last quarter.  Finally, GAMMA Investing LLC grew its holdings in shares of  Cabot by 12.3% in the second quarter. GAMMA Investing LLC now owns 1,909 shares of the specialty chemicals company's stock worth $143,000 after acquiring an additional 209 shares during the period. 93.18% of the stock is owned by hedge funds and other institutional investors. </p><h2>Cabot Price Performance</h2><p>Shares of NYSE:CBT opened at $65.29 on Friday. The company has a market capitalization of $3.45 billion, a P/E ratio of 10.86, a P/E/G ratio of 3.36 and a beta of 0.90. Cabot Corporation has a 1-year low of $58.33 and a 1-year high of $108.93. The firm's 50 day simple moving average is $66.81 and its two-hundred day simple moving average is $73.54. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.61 and a quick ratio of 1.08. </p><ul><li>Cabot Boosting Production In Lithium Battery Chain For EV Market</li></ul><p>Cabot (NYSE:CBT - Get Free Report) last announced its quarterly earnings data on Monday, November 3rd. The specialty chemicals company reported $1.70 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.72 by ($0.02). The firm had revenue of $899.00 million during the quarter, compared to analysts' expectations of $967.02 million. Cabot had a return on equity of 24.55% and a net margin of 8.91%.The business's revenue for the quarter was down 10.2% on a year-over-year basis. During the same period last year, the company earned $1.80 earnings per share. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS.  Research analysts expect that  Cabot Corporation will post 7.57 EPS for the current fiscal year. </p><h2>Cabot Announces Dividend</h2><p>The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 12th. Stockholders of record on Friday, November 28th will be given a $0.45 dividend. This represents a $1.80 annualized dividend and a dividend yield of 2.8%. The ex-dividend date is Friday, November 28th. Cabot's payout ratio is presently 29.95%. </p><h2>Wall Street Analyst Weigh In</h2><p>A number of research analysts have weighed in on the company. JPMorgan Chase &amp; Co. lowered their target price on Cabot from $75.00 to $54.00 and set an &#34;underweight&#34; rating on the stock in a report on Friday, November 28th. Zacks Research cut shares of Cabot from a &#34;hold&#34; rating to a &#34;strong sell&#34; rating in a research note on Friday, November 7th. UBS Group cut their target price on shares of Cabot from $82.00 to $65.00 and set a &#34;neutral&#34; rating for the company in a research report on Wednesday, November 5th. Weiss Ratings  reiterated a &#34;hold (c)&#34; rating on shares of Cabot in a research report on Wednesday, October 8th. Finally, Mizuho dropped their price target on shares of Cabot from $78.00 to $72.00 and set an &#34;outperform&#34; rating on the stock in a research note on Monday, November 17th. One investment analyst  has rated the stock with a Buy rating, two have given a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat.com, Cabot  has an average rating of &#34;Reduce&#34; and an average price target of $63.67.</p><p><b>Check Out Our Latest Analysis on Cabot</b></p><h2>About Cabot</h2> (Free Report)<p>Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.</p><h2>See Also</h2><ul><li>Five stocks we like better than Cabot</li><li>EV Stocks and How to Profit from Them </li><li>Rocket Lab’s Big Rebound? Analysts Suggest the Dip's a Gift</li><li>How to Profit From Growth Investing </li><li>Meta’s AI Moment? New SAM 3 Model Has Wall Street Turning Bullish</li><li>Want to Profit on the Downtrend? Downtrends, Explained.</li><li>Snowflake Stock: The Dip That Smart Investors Are Buying Right Now</li></ul><p><strong>Want to see what other hedge funds are holding CBT?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNCVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNCVA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Cabot Right Now?</h2><p>Before you consider Cabot, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.</p><p>While Cabot currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Norges Bank acquired 689,470 shares of Cabot Corporation, valued at $51.71 million, during Q2. This purchase represents 1.30% ownership of Cabot. Other hedge funds also adjusted their positions in Cabot. Cabot's stock opened at $65.29, with a market cap of $3.45 billion. Analysts have mixed ratings on Cabot, with target prices ranging from $54 to $72. Cabot announced a quarterly dividend of $0.45, payable on December 12th.</p>

Norges Bank Buys Shares of 689,470 Cabot Corporation $CBT